Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy. - Warren G; Osborn M; Tsantoulas C; David-Pereira A; Cohn D; Duffy P; Ruston L; Johnson C; Bradshaw H; Kaczocha M; Ojima I; Yates A; et al. (The journal of pain, 2024)